Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference
DURHAM, N.C., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Rob Claypoole, Bioventus President and Chief ...
Could the presentation provide insight into capitalâallocation priorities, such as M&A or R&D spending?
What are the potential longâterm implications for market share if the companyâs growth strategies are successful?
Is there any indication that the conference will affect analyst coverage or target price revisions?
21 days ago